John Fowler
2021
In 2021, John Fowler earned a total compensation of $5.6M as Chief Executive Officer at Kezar Life Sciences, a 346% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $326,025 |
|---|---|
| Option Awards | $4,740,360 |
| Salary | $567,000 |
| Other | $12,032 |
| Total | $5,645,417 |
Fowler received $4.7M in option awards, accounting for 84% of the total pay in 2021.
Fowler also received $326K in non-equity incentive plan, $567K in salary and $12K in other compensation.
Rankings
In 2021, John Fowler's compensation ranked 2,256th out of 12,415 executives tracked by ExecPay. In other words, Fowler earned more than 81.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,256 out of 12,415 | 82nd |
Division Manufacturing | 883 out of 5,505 | 84th |
Major group Chemicals And Allied Products | 337 out of 2,375 | 86th |
Industry group Drugs | 291 out of 2,096 | 86th |
Industry Pharmaceutical Preparations | 188 out of 1,546 | 88th |
Source: SEC filing on April 26, 2022.
Fowler's colleagues
We found two more compensation records of executives who worked with John Fowler at Kezar Life Sciences in 2021.